These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 25857641)

  • 1. Germline and somatic mutations in meningiomas.
    Smith MJ
    Cancer Genet; 2015 Apr; 208(4):107-14. PubMed ID: 25857641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARCB1 mutations are not a common cause of multiple meningiomas.
    Hadfield KD; Smith MJ; Trump D; Newman WG; Evans DG
    J Med Genet; 2010 Aug; 47(8):567-8. PubMed ID: 20472658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted next-generation sequencing for differential diagnosis of neurofibromatosis type 2, schwannomatosis, and meningiomatosis.
    Louvrier C; Pasmant E; Briand-Suleau A; Cohen J; Nitschké P; Nectoux J; Orhant L; Zordan C; Goizet C; Goutagny S; Lallemand D; Vidaud M; Vidaud D; Kalamarides M; Parfait B
    Neuro Oncol; 2018 Jun; 20(7):917-929. PubMed ID: 29409008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.
    van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ
    Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas.
    Christiaans I; Kenter SB; Brink HC; van Os TA; Baas F; van den Munckhof P; Kidd AM; Hulsebos TJ
    J Med Genet; 2011 Feb; 48(2):93-7. PubMed ID: 20930055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole exome sequencing in a case of sporadic multiple meningioma reveals shared NF2, FAM109B, and TPRXL mutations, together with unique SMARCB1 alterations in a subset of tumor nodules.
    Torres-Martín M; Kusak ME; Isla A; Burbano RR; Pinto GR; Melendez B; Castresana JS; Rey JA
    Cancer Genet; 2015 Jun; 208(6):327-32. PubMed ID: 25981829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas.
    Smith MJ; O'Sullivan J; Bhaskar SS; Hadfield KD; Poke G; Caird J; Sharif S; Eccles D; Fitzpatrick D; Rawluk D; du Plessis D; Newman WG; Evans DG
    Nat Genet; 2013 Mar; 45(3):295-8. PubMed ID: 23377182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SWI/SNF chromatin remodeling complex alterations in meningioma.
    Gill CM; Loewenstern J; Rutland JW; Arib H; Pain M; Umphlett M; Kinoshita Y; McBride RB; Bederson J; Donovan M; Sebra R; Fowkes M; Shrivastava RK
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3431-3440. PubMed ID: 33715086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric clear cell meningioma involving the middle cranial fossa in the context of NF2 and SMARCE1 mutations.
    Libert DM; Prayson RA
    Ann Diagn Pathol; 2020 Jun; 46():151516. PubMed ID: 32311644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMARCE1 mutations in pediatric clear cell meningioma: case report.
    Evans LT; Van Hoff J; Hickey WF; Smith MJ; Evans DG; Newman WG; Bauer DF
    J Neurosurg Pediatr; 2015 Sep; 16(3):296-300. PubMed ID: 26114992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas.
    Sestini R; Bacci C; Provenzano A; Genuardi M; Papi L
    Hum Mutat; 2008 Feb; 29(2):227-31. PubMed ID: 18072270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-based analysis of two SMARCB1 mutations associated with familial schwannomatosis with meningiomas.
    Melean G; Velasco A; Hernández-Imaz E; Rodríguez-Álvarez FJ; Martín Y; Valero A; Hernández-Chico C
    Neurogenetics; 2012 Aug; 13(3):267-74. PubMed ID: 22752724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas.
    Smith MJ; Wallace AJ; Bennett C; Hasselblatt M; Elert-Dobkowska E; Evans LT; Hickey WF; van Hoff J; Bauer D; Lee A; Hevner RF; Beetz C; du Plessis D; Kilday JP; Newman WG; Evans DG
    J Pathol; 2014 Dec; 234(4):436-40. PubMed ID: 25143307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT.
    Jungwirth G; Warta R; Beynon C; Sahm F; von Deimling A; Unterberg A; Herold-Mende C; Jungk C
    Acta Neuropathol Commun; 2019 Aug; 7(1):140. PubMed ID: 31470906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic landscape of meningioma.
    Yuzawa S; Nishihara H; Tanaka S
    Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
    Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
    Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.
    Evans DGR; Salvador H; Chang VY; Erez A; Voss SD; Druker H; Scott HS; Tabori U
    Clin Cancer Res; 2017 Jun; 23(12):e54-e61. PubMed ID: 28620005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic/molecular alterations of meningiomas and the signaling pathways targeted.
    Domingues P; González-Tablas M; Otero Á; Pascual D; Ruiz L; Miranda D; Sousa P; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
    Oncotarget; 2015 May; 6(13):10671-88. PubMed ID: 25965831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on the article "Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri" by van den Munckhof et al.
    Prescott TE; Smith MJ; Evans DG
    Neurogenetics; 2012 Feb; 13(1):103-4. PubMed ID: 22203059
    [No Abstract]   [Full Text] [Related]  

  • 20. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.